🇺🇸 FDA
Patent

US 6685948

Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines

expired A61KA61K2039/5254

Quick answer

US patent 6685948 (Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/5254